Los Angeles Capital Management
PRCT icon

Los Angeles Capital Management’s Procept Biorobotics PRCT Stock Holding History

Los Angeles Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.41K Hold
284
– – ﹤0.01% 2075
2026
Q1 		$7.1K Sell
284
-5,672
-95% -$160K ﹤0.01% 2025
2025
Q4 		$205K Buy
+5,956
New +$198K ﹤0.01% 1234
2025
Q3 		– Sell
-13,832
Closed -$797K – 1505
2025
Q2 		$797K Sell
13,832
-15,863
-53% -$897K ﹤0.01% 714
2025
Q1 		$1.73M Buy
29,695
+16,715
+129% +$1.14M 0.01% 432
2024
Q4 		$1.05M Buy
12,980
+8,399
+183% +$718K ﹤0.01% 605
2024
Q3 		$367K Buy
+4,581
New +$325K ﹤0.01% 950

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Los Angeles Capital Management's PRCT Position: Q2 2026 in Review

Los Angeles Capital Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 284 shares worth $6.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Los Angeles Capital Management first reported a position in PRCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.73M in Q1 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Los Angeles Capital Management held 284 shares of Procept Biorobotics worth $6.41K as of Q2 2026.
  • Los Angeles Capital Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2075 holding.
  • Los Angeles Capital Management first reported a position in Procept Biorobotics in Q3 2024 and has held it in 7 quarters since.
  • Los Angeles Capital Management's Procept Biorobotics position peaked at $1.73M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.